BSX vs LINE · P/E 20, rev $16.75B vs rev $5.34B
Boston Scientific Corp (BSX) versus Lineage, Inc. Common Stock (LINE) — a side-by-side from cached financials, not a winner call.
Boston Scientific Corp (BSX) is a medical devices company listed on US.
Lineage, Inc. Common Stock (LINE) is a reit - industrial company listed on NASDAQ.
Latest reported BSX revenue for 2024-12-31 was $16.75B. Net income was $1.85B. Revenue was up 17.6% from 2023-12-31 to 2024-12-31. BSX currently screens at market cap $71.81B and trailing P/E 20.2.
Latest reported LINE revenue for 2024-12-31 was $5.34B. Net income was -$751.0M. Revenue was down 0.0% from 2023-12-31 to 2024-12-31. LINE currently screens at market cap $10.41B.
BSX currently screens at market cap $71.81B and trailing P/E 20.2. LINE currently screens at market cap $10.41B.
Not investment advice. Open the BSX and LINE stock pages for the full models.
Not investment advice.